Document is current
Any future updates will be listed below
-
Authors
Secker, Christopher
Fackeldey, Konstantin
Weber, Marcus
Ray, Sourav
Gorgulla, Christoph
Schütte, Christof
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (235221301)
Deutsche Forschungsgemeinschaft,Germany (390685689)
Zuse-Institut Berlin
- License Information
-
More Information
Article History
Received: 12 April 2023
Accepted: 21 August 2023
First Online: 19 September 2023
Declarations
:
: The authors declare the following competing interests: C.G. is a cofounder of Quantum Therapeutics Inc., a company that uses computational methods for drug development. C.G. is also cofounder of Virtual Discovery Inc., which is a fee-for-service company for computational drug discovery.
